Endothelial dysfunction is associated with the severity of cerebral small vessel disease

Hypertension Research

Volumn 38, Issue 4, 2015, Pages 291-297

  Nezu, Tomohisa ^a   Hosomi, Naohisa ^a   Aoki, Shiro ^a   Kubo, Satoshi ^a   Araki, Mutsuko ^a   Mukai, Tomoya ^a   Takahashi, Tetsuya ^a   Maruyama, Hirofumi ^a   Higashi, Yukihito ^b   Matsumoto, Masayasu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

cerebral microbleeds; cerebral small vessel disease; endothelial dysfunction; white matter lesions

Indexed keywords

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FAZEKAS CLASSIFICATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; WHITE MATTER LESION; CAROTID ARTERY; COMPLICATION; DIABETIC ANGIOPATHY; DRUG EFFECTS; ECHOGRAPHY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; VASCULAR ENDOTHELIUM; VASODILATATION; WHITE MATTER;

GLYCERYL TRINITRATE; VASODILATOR AGENT;

AGED; CAROTID ARTERIES; CEREBRAL SMALL VESSEL DISEASES; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NITROGLYCERIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; VASODILATION; VASODILATOR AGENTS; WHITE MATTER;

EID: 84926669155     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.4     Document Type: Article

References (42)

1. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke 1997; 28: 652-659.
2. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
3. Kalaria RN. Cerebrovascular disease and mechanisms of cognitive impairment: Evidence from clinicopathological studies in humans. Stroke 2012; 43: 2526-2534.
4. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM, CASES Investigators. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-1024.
5. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A, Kucinski T, Lacei O, Liebeskind DS, Rother J, Rosso C, Samson Y, Saver JL, Yan B, MR Stroke Group. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37: 2463-2466.
6. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12: 358-370.
7. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010; 119: 277-290.
8. Isa K, Sakima A, Sakima H, Nakachi K, Kinjyo K, Ohya Y. Association between the intima-media thickness of the brachiocephalic trunk and white matter hyperintensity in brain MRI. Hypertens Res 2013; 36: 980-984.
9. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-812.
10. Yao H, Sadoshima S, Ibayashi S, Kuwabara Y, Ichiya Y, Fujishima M. Leukoaraiosis and dementia in hypertensive patients. Stroke 1992; 23: 1673-1677.
11. Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, Siscovick DS, Tracy RP, Longstreth WT Jr. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: The Cardiovascular Health Study. Stroke 2008; 39: 1952-1959.
12. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41: e434-e442.
13. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
14. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
15. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
16. Gokce N, Keaney JF, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567-1572.
17. Östlund E, Al-Nashi M, Hamad RR, Larsson A, Eriksson M, Bremme K, Kahan T. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res 2013; 36: 1081-1087.
18. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis. Int J Cardiol 2013; 168: 344-351.
19. Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007; 38: 308-312.
20. Hosomi N, Aoki S, Matsuo K, Deguchi K, Masugata H, Murao K, Ichihara N, Ohyama H, Dobashi H, Nezu T, Ohtsuki T, Yasuda O, Soejima H, Ogawa H, Izumi Y, Kohno M, Tanaka J, Matsumoto M. Association of serum anti-periodontal pathogen antibody with ischemic stroke. Cerebrovasc Dis 2012; 34: 385-392.
21. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
22. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, March EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 1993; 24: 35-41.
23. Handa N, Matsumoto M, Maeda H, Hougaku H, Kamada T. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA Study). Stroke 1995; 26: 1781-1786.
24. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, Higashi Y. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 2012; 126: 598-603.
25. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Higashi Y. Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32: 2295-2303.
26. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 1987; 149: 351-356.
27. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler MM, Microbleed Study Group. Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol 2009; 8: 165-174.
28. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
29. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, Miyazawa H, Hishinuma T, Yanai K, Sekita Y, Yamada K. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990; 28: 378-383.
30. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 1990; 21: 1694-1699.
31. Nezu T, Yokota C, Uehara T, Yamauchi M, Fukushima K, Toyoda K, Matsumoto M, Iida H, Minematsu K. Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies. J Cereb Blood Flow Metab 2012; 32: 844-850.
32. Birns J, Jarosz J, Markus HS, Kalra L. Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiatry 2009; 80: 1093-1098.
33. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999; 52: 578-583.
34. Fu JH, Lu CZ, Hong Z, Dong Q, Ding D, Wong KS. Relationship between cerebral vasomotor reactivity and white matter lesions in elderly subjects without large artery occlusive disease. J Neuroimaging 2006; 16: 120-125.
35. Kozera GM, Dubaniewicz M, Zdrojewski T, Madej-Dmochowska A, Mielczarek M, Wojczal J, Chwojnicki K, Swierblewska E, Schminke U, Wyrzkowski B, Nyka WM, SOPKARD Study Group. Cerebral vasomotor reactivity and extent of white matter lesions in middle-aged men with arterial hypertension: A pilot study. Am J Hypertens 2010; 23: 1198-1203.
36. Maeda H, Matsumoto M, Handa N, Hougaku H, Ogawa S, Itoh T, Tsukamoto Y, Kamada T. Reactivity of cerebral blood flow to carbon dioxide in various types of ischemic cerebrovascular disease: Evaluation by the transcranial Doppler method. Stroke 1993; 24: 670-675.
37. Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: Correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994; 14: 763-770.
38. Chen PL, Wang PY, Sheu WH, Chen YT, Ho YP, Hu HH, Hsu HY. Changes of brachial flow-mediated vasodilation in different ischemic stroke subtypes. Neurology 2006; 67: 1056-1058.
39. Pretnar-Oblak J, Sabovic M, Sebestjen M, Pogacnik T, Zaletel M. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke 2006; 37: 2540-2545.
40. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Higashi Y. Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013; 33: 1401-1408.
41. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605.
42. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsh WM. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study. Acta Neuropathol 2010; 119: 291-302.